DaVita
DVA
#2359
Rank
C$10.96 B
Marketcap
C$153.42
Share price
-2.01%
Change (1 day)
-30.69%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$13.99

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.82. In 2024 the company made an earnings per share (EPS) of C$15.34 an increase over its 2023 EPS that were of C$10.58.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$13.99-8.81%
2024C$15.3444.94%
2023C$10.5827.26%
2022C$8.32-35.56%
2021C$12.9144.1%
2020C$8.9619.7%
2019C$7.48540.48%
2018C$1.17-76.07%
2017C$4.88-19.31%
2016C$6.05242.52%
2015C$1.77-62.87%
2014C$4.7613.43%
2013C$4.198.45%
2012C$3.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
C$20.44 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.64-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
C$29.69 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$14.25 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA